Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Operating Expenses: 2018-2024

Historic Operating Expenses for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $174.6 million.

  • Gossamer Bio's Operating Expenses rose 43.80% to $62.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.9 million, marking a year-over-year increase of 15.00%. This contributed to the annual value of $174.6 million for FY2024, which is 4.97% down from last year.
  • Latest data reveals that Gossamer Bio reported Operating Expenses of $174.6 million as of FY2024, which was down 4.97% from $183.8 million recorded in FY2023.
  • Over the past 5 years, Gossamer Bio's Operating Expenses peaked at $234.0 million during FY2020, and registered a low of $174.6 million during FY2024.
  • Its 3-year average for Operating Expenses is $192.3 million, with a median of $183.8 million in 2023.
  • Per our database at Business Quant, Gossamer Bio's Operating Expenses increased by 25.69% in 2020 and then decreased by 15.94% in 2023.
  • Gossamer Bio's Operating Expenses (Yearly) stood at $234.0 million in 2020, then fell by 7.62% to $216.1 million in 2021, then increased by 1.14% to $218.6 million in 2022, then fell by 15.94% to $183.8 million in 2023, then declined by 4.97% to $174.6 million in 2024.